| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 30, 2019HIMSS Tradeshow News
PS3G Inc. will be exhibiting its Health Technology platform – DocVilla in HIMSS 2020 Global Health Conference. DocVilla is inspired by HIMSS20 theme "Be the Change" and is a HIPAA compliant,...
-
Sep 30, 2019Virtual Press Office and PR Newswire: General Trade show news
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune...
-
Sep 30, 2019Virtual Press Office and PR Newswire: General Trade show news
The Hispanic Information Technology Executive Council (HITEC) is pleased to recognize Darrell Higueros, CEO of Next Generation, Inc. (NGI) as the 2019 HITEC Member of the Year. The HITEC Member of...
-
Sep 30, 2019Virtual Press Office and PR Newswire: General Trade show news
Transcepta will be exhibiting in Booth #512 at IOFM's AP & P2P Conference and Expo, Fall 2019, Oct 15-17, in Scottsdale, AZ. This tremendous industry event brings together highly innovative...
-
Sep 30, 2019Solar Power International News Releases from Cision PR Newswire
Contemporary Amperex Technology Co., Limited (CATL), the world's leading battery manufacturer, made a successful U.S. debut at Solar Power International 2019 (SPI), underscoring its leadership in...
-
Sep 30, 2019Virtual Press Office and PR Newswire: General Trade show news
Initiated new PoS blockchain development for IoT and payment service aiming to launch in 1Q 2020 Leads blockchain-based digital transformation by providing enterprise solution to public and...
-
Sep 30, 2019Virtual Press Office and PR Newswire: General Trade show news
Bayer and XAG has recently collaborated in Hangzhou, China to host a crop dusting drone demonstration on citrus trees. Justin Gong, Co-founder and Vice President of XAG, together with Bayer's crop...
-
Sep 29, 2019Virtual Press Office and PR Newswire: General Trade show news
Elevar Therapeutics announced data from the ANGEL trial, a randomized phase 3 study of rivoceranib (also known as apatinib) plus best supportive care in patients with gastric or gastroesophageal...
-
Sep 29, 2019Virtual Press Office and PR Newswire: General Trade show news
The study results presented at the ERS 2019 as a late breaking abstract demonstrated positive safety and tolerance in healthy volunteers Data demonstrated LPA inhibition of BBT-877 up to 90% in...
-
Sep 29, 2019Virtual Press Office and PR Newswire: General Trade show news
Agendia Inc., a world leader in precision oncology for breast cancer, will present new data from their on-going clinical research at the European Society for Medical Oncology (ESMO) Congress 2019,...
